![IJMS | Free Full-Text | Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver IJMS | Free Full-Text | Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver](https://www.mdpi.com/ijms/ijms-19-02199/article_deploy/html/images/ijms-19-02199-g001.png)
IJMS | Free Full-Text | Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver
![Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors? | SpringerLink Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors? | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40257-020-00579-z/MediaObjects/40257_2020_579_Fig1_HTML.png)
Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors? | SpringerLink
![Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives - Gastroenterology Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives - Gastroenterology](https://www.gastrojournal.org/cms/asset/2b26323d-30d0-4a74-a734-19065e6c9cb0/gr1.jpg)
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives - Gastroenterology
![Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities - ScienceDirect Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508522000786-gr2.jpg)
Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities - ScienceDirect
![JCM | Free Full-Text | A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease JCM | Free Full-Text | A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease](https://www.mdpi.com/jcm/jcm-10-04990/article_deploy/html/images/jcm-10-04990-g001.png)
JCM | Free Full-Text | A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
![Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring - ScienceDirect Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508519410007-fx1.jpg)
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring - ScienceDirect
![New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease](https://assets-global.website-files.com/5db26e2d55881e73a90f2b5d/5df0de58797c02c64a8742b5_content-full-width-675.png)
New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
![Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring? | Nature Reviews Gastroenterology & Hepatology Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring? | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41575-020-0352-2/MediaObjects/41575_2020_352_Fig1_HTML.png)
Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring? | Nature Reviews Gastroenterology & Hepatology
![Medical management of moderate to severe luminal and perianal fistulizing Crohn's disease - American Gastroenterological Association Medical management of moderate to severe luminal and perianal fistulizing Crohn's disease - American Gastroenterological Association](https://gastro.org/wp-content/uploads/2022/03/gr2.1.jpg)
Medical management of moderate to severe luminal and perianal fistulizing Crohn's disease - American Gastroenterological Association
![Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study - The Lancet Rheumatology Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/9461de2a-ed3f-4139-8675-3cf3d870b2eb/gr1_lrg.jpg)
Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study - The Lancet Rheumatology
![JCM | Free Full-Text | Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease—Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics JCM | Free Full-Text | Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease—Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics](https://www.mdpi.com/jcm/jcm-11-06173/article_deploy/html/images/jcm-11-06173-g001.png)
JCM | Free Full-Text | Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease—Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics
![American Gastroenterological Association (AGA) on Twitter: "New clinical guideline on role of therapeutic drug monitoring in the management of #IBD now available in @AGA_Gastro https://t.co/yzwtV2FaEj https://t.co/IxiVz1xfST" / Twitter American Gastroenterological Association (AGA) on Twitter: "New clinical guideline on role of therapeutic drug monitoring in the management of #IBD now available in @AGA_Gastro https://t.co/yzwtV2FaEj https://t.co/IxiVz1xfST" / Twitter](https://pbs.twimg.com/media/DIqT3qEUQAAnlBD.jpg)
American Gastroenterological Association (AGA) on Twitter: "New clinical guideline on role of therapeutic drug monitoring in the management of #IBD now available in @AGA_Gastro https://t.co/yzwtV2FaEj https://t.co/IxiVz1xfST" / Twitter
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease
![New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease](https://assets-global.website-files.com/5db26e2d55881e73a90f2b5d/5df0de585a7b0f41aca45daf_content-full-width-675.png)